This brand name is authorized in Mexico
The drug SPASMOPRIV contains one active pharmaceutical ingredient (API):
1
Fenoverine
UNII N274ZQ6PZJ - FENOVERINE
|
Fenoverine is a calcium antagonist that inhibits the calcium channels at significant sites in the calcium transport system. It stops the rapid calcium influx through the voltage-dependent channels and inhibits the rapid calcium release from the intracellular storage sites. This induces an effect on the strong (transient and prolonged), asynchronous spasmodic contractions. Fenoverine is a potent, musculotropic, spasmolytic agent that affects primarily the gastrointestinal tract, bile duct, and female genital organs. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
SPASMOPRIV FORTE Capsule | Web Search | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A03AX05 | Fenoverine | A Alimentary tract and metabolism → A03 Drugs for functional gastrointestinal disorders → A03A DRUGS FOR FUNCTIONAL BOWEL DISORDERS → A03AX Other drugs for functional bowel disorders |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: MX | Comisiรณn Federal para la Protecciรณn contra Riesgos Sanitarios | Identifier(s): 538M89 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.